Sökning: onr:"swepub:oai:DiVA.org:uu-169342" > High dose ursodeoxy...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04380naa a2200565 4500 | |
001 | oai:DiVA.org:uu-169342 | |
003 | SwePub | |
008 | 120228s2012 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:0f29839c-e4ad-4ace-83ff-1422806d66a0 | |
009 | oai:prod.swepub.kib.ki.se:123969517 | |
009 | oai:DiVA.org:umu-52644 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1693422 URI |
024 | 7 | a https://doi.org/10.1111/j.1365-2036.2011.04966.x2 DOI |
024 | 7 | a https://lup.lub.lu.se/record/24162502 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1239695172 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-526442 URI |
040 | a (SwePub)uud (SwePub)lud (SwePub)kid (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lindstrom, L.u Karolinska Institutet4 aut |
245 | 1 0 | a High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia |
264 | c 2012-01-05 | |
264 | 1 | a Malden :b Wiley,c 2012 |
338 | a print2 rdacarrier | |
520 | a Background Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) have a high risk of developing colorectal cancer and dysplasia. Ursodeoxycholic acid (UDCA) has been suggested to have chemopreventive effects on the development of colorectal cancer and dysplasia but long-term data and larger trials are lacking. Aim To evaluate the effect of high dose (17-23 mg/kg/day) UDCA on colorectal neoplasia in a cohort of patients with PSC and IBD. Methods From our previous 5-year randomised controlled trial of UDCA vs. placebo in PSC, we performed a follow-up of 98 patients with concomitant IBD from entry of the trial 1996-1997 until 2009 for development of colorectal cancer or dysplasia. Results The total follow-up time was 760 person-years. Dysplasia/cancer-free survival was compared between placebo-(n = 50) and UDCA-treated (n = 48) patients. There was a similar frequency of dysplasia or cancer after 5 years between patients originally assigned to UDCA or placebo (13% vs. 16%) and no difference in dysplasia/cancer-free survival (P = 0.46, log rank test). At the end of 2009 no difference in cancer-free survival was detected, 30% of the placebo patients compared with 27% of UDCA patients had developed colorectal cancer or dysplasia. Conclusions Long-term high dose ursodeoxycholic acid does not prevent colorectal cancer or dysplasia in patients with primary sclerosing cholangitis-associated inflammatory bowel disease. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
700 | 1 | a Boberg, K. M.4 aut |
700 | 1 | a Wikman, O.4 aut |
700 | 1 | a Friis-Liby, I.4 aut |
700 | 1 | a Hultcrantz, R.u Karolinska Institutet4 aut |
700 | 1 | a Prytz, Hanneu Lund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-hpr |
700 | 1 | a Sandberg-Gertzen, H.4 aut |
700 | 1 | a Sangfelt, Peru Uppsala universitet,Institutionen för medicinska vetenskaper4 aut0 (Swepub:uu)persangf |
700 | 1 | a Rydning, A.4 aut |
700 | 1 | a Folvik, G.4 aut |
700 | 1 | a Gangsoy-Kristiansen, M.4 aut |
700 | 1 | a Danielsson, Åkeu Umeå universitet,Medicin4 aut0 (Swepub:umu)akda0001 |
700 | 1 | a Bergquist, Annikau Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutetb Medicin, Lund4 org |
773 | 0 | t Alimentary Pharmacology and Therapeuticsd Malden : Wileyg 35:4, s. 451-457q 35:4<451-457x 0269-2813x 1365-2036 |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2011.04966.x |
856 | 4 | u http://dx.doi.org/10.1111/j.1365-2036.2011.04966.xy FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-169342 |
856 | 4 8 | u https://doi.org/10.1111/j.1365-2036.2011.04966.x |
856 | 4 8 | u https://lup.lub.lu.se/record/2416250 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:123969517 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-52644 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy